ReviewClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2021
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases.
Konstantinos Papamichael et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it